Gencove expanding whole genome sequencing

/

Gencove raises $3M investment led by Spero Ventures to expand genome sequencing platform

Gencove expanding whole genome sequencing. Genome Media

NEW YORK, /PRNewswire/ -- Gencove, the leading low-pass genome sequencing platform, announced today a $3 million investment led by Spero Ventures. Alexandria Venture Investments and Burst Capital participated in the round, along with existing investors Third Kind Venture Capital and Version One Ventures. The funding will be used to develop new applications for agricultural markets as well as expand Gencove's commercial operations in human genetics. Shripriya Mahesh, partner at Spero, will join Gencove's board of directors.

"Genomics will be foundational to the health and well-being of humanity and the planet," said Shripriya Mahesh. "We are excited partner with Gencove in its mission to bring affordable whole genome sequencing to customers and industries that have never before been able to affordably integrate it at scale."


READ MORE …

3 Technologies That Could Create Trillion-Dollar Markets Over the Next Decade

/

Go back to the typical household in 1950, and you would see much that you would recognize: washing machines, vacuum cleaners, cars, TVs. But go back 50 years earlier, to 1900, and most of us would find a world that was utterly foreign, and exhausting. Daily chores like cooking and washing took hours of backbreaking labor. That’s because in the early 20th century, electricity and internal combustion completely changed how we live, transforming our cities, our homes, how we shop, eat, work, and just about every other facet of daily existence.

We’re on the cusp of a similar point today, except it is not just two technologies that are poised to change the world, but three of them: gene editing, new computing architectures, and materials science are just beginning to make the leap from lab to market. Taken together, these could be as transformative as electricity and internal combustion, which kicked off a 50-year productivity boom.

READ MORE…

Think about Thermo Fisher ...

/

ARE INVESTORS UNFAIRLY PUNISHING THERMO FISHER SCIENTIFIC INC. (TMO)?

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) recorded -1.92% loss during trading session on March 5th, 2019. The script traded as low as $253.405 and last traded at $254.46. 3.76 million shares changed exchanged hands during trading, a drop of -105.57% from the 30-day average session volume of 1.83M shares. The firm had previously closed at $259.45. The company has $402.00M outstanding shares, a price-to-earnings ratio of 35.14, price-to-earnings-growth ratio of 4.20and a beta of 1.14. The company has a RSI of 60.52, ATR of 4.29 and a volatility of 2.31% this week. TMO has a 52 week low price of $199.85 and a 52 week high price of $266.18.

READ MORE …